Você procurou por: alogliptin (Inglês - Dinamarquês )

alogliptin/pioglitazone
alogliptin/pioglitazon

alogliptin as monotherapy
alogliptin som enkeltstofsbehandling

risk related to alogliptin
risiko relateret til alogliptin

incresync alogliptin / pioglitazone
incresync alogliptin / pioglitazon

vipidia 25 mg tablets alogliptin
vipidia 25 mg tabletter alogliptin

the active substance is alogliptin.
aktivt stof: alogliptin.

alogliptin as add-on therapy to metformin
alogliptin som tillæg til metformin

alogliptin 25 mg once daily (n=128)
alogliptin 25 mg én gang dagligt (n =

vipidia 25 mg film-coated tablets alogliptin
vipidia 25 mg filmovertrukne tabletter alogliptin

alogliptin does not work when the blood glucose is low.
alogliptin virker ikke, når blodsukkeret er lavt.

incresync 25 mg/30 mg tablets alogliptin/pioglitazone
incresync 25 mg/30 mg tabletter alogliptin/pioglitazon

alogliptin and metformin are substantially excreted by the kidney.
alogliptin og metformin bliver i vid udstrækning udskilt af nyrerne.

alogliptin 25 mg once daily with metformin (n=203)
alogliptin 25 mg én gang dagligt sammen med metformin (n = 203)

combination of alogliptin with other anti-diabetic medicinal products
kombineret anvendelse af alogliptin og andre antidiabetiske lægemidler

alogliptin 25 mg once daily with a sulphonylurea (n=197)
alogliptin 25 mg én gang dagligt sammen med et sulfonylurinstof

alogliptin may be administered without regard to the timing of dialysis.
alogliptin kan gives uafhængigt af tidspunktet for dialyse.

each 25 mg tablet contains alogliptin benzoate equivalent to 25 mg alogliptin,
hver 25 mg tablet indeholder alogliptinbenzoat svarende til 25 mg alogliptin.

incresync 25 mg/30 mg film-coated tablets alogliptin/pioglitazone
incresync 25 mg/30 mg filmovertrukne tabletter alogliptin/pioglitazon

alogliptin 25 mg once daily with insulin + metformin (n=126)
alogliptin 25 mg én gang dagligt sammen med insulin  metformin (n = 126)

in clinical studies of alogliptin, anaphylactic reactions were reported with a low incidence.
i kliniske studier med alogliptin blev anafylaktiske reaktioner indberettet med en lav forekomst.